Online ahead of print
Based on the previous studies, the key strategies for the management of PH following bariatric surgery are dietary and lifestyle modifications, pharmacological therapy, and surgical interventions [55, 56]
When to Consider Testing Testing may be useful: Before starting a GLP-1 medicine After a meaningful treatment change When diabetes goals are not being met When persistent gastrointestinal symptoms develop When food or fluid intake has significantly decreased When kidney or liver risk is already present When a prior result was abnormal When a healthcare provider recommends follow-up Testing frequency should be based on individual risk rather than an automatic monthly or quarterly panel for everyone
Some research has demonstrated systemic anti-inflammatory and neuroprotective benefits in patients with diabetes, but specific data regarding risk for age-related macular degeneration (AMD) in those without the disease is minimal
You should not use GLP-1 medications if you have: Personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous severe allergic reaction to semaglutide or liraglutide Current pregnancy or planning to become pregnant History of pancreatitis (requires careful evaluation) Severe gastrointestinal disease Additionally, these medications are not typically recommended for patients under 18 years old, though Saxenda has some pediatric approval for adolescents 12 and older with obesity
Body Contouring After Weight Loss Losing weight is a major accomplishment, but stubborn areas of fat and skin laxity can still remain